Clinical Trial Update: Efficacy and Safety of Human Neuregulin-1 to Treat Stable Chronic Heart Failure [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated the efficacy and safety of human neuregulin-1 in patients with stable chronic heart failure. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Human Neuregulin-1 (neuregulin-1)

Snippet

Sponsor: Zensun Sci. & Tech. Co., Ltd. | Conditions: Chronic Heart Failure | Phase 2 | Status: COMPLETED